Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Lügering N[au]:

Search results

Items: 1 to 50 of 58

1.

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2010 Apr;55(4):1066-78. doi: 10.1007/s10620-009-0846-9. Epub 2009 Jun 10.

PMID:
19513841
2.

Long-term effectiveness of azathioprine in IBD beyond 4 years: a European multicenter study in 1176 patients.

Holtmann MH, Krummenauer F, Claas C, Kremeyer K, Lorenz D, Rainer O, Vogel I, Böcker U, Böhm S, Büning C, Duchmann R, Gerken G, Herfarth H, Lügering N, Kruis W, Reinshagen M, Schmidt J, Stallmach A, Stein J, Sturm A, Galle PR, Hommes DW, D'Haens G, Rutgeerts P, Neurath MF.

Dig Dis Sci. 2006 Sep;51(9):1516-24. Epub 2006 Aug 22.

PMID:
16927148
3.

[Virus persistence in hepatitis C: lifelong infection despite therapy?].

Gockel HR, Heidemann J, Lügering N.

Med Klin (Munich). 2006 May 15;101(5):378-83. Review. German.

PMID:
16685484
4.

Virtual colonography: identification and differentiation of colorectal lesions using multi-detector computed tomography.

Wessling J, Domagk D, Lugering N, Schierhorn S, Heindel W, Domschke W, Fischbach R.

Scand J Gastroenterol. 2005 Apr;40(4):468-76.

PMID:
16028443
5.

Stable remission after administration of rituximab in a patient with primary hepatic marginal zone B-cell lymphoma.

Gockel HR, Heidemann J, Lugering A, Mesters RM, Parwaresch R, Domschke W, Lugering N.

Eur J Haematol. 2005 May;74(5):445-7.

PMID:
15813921
6.

Characterization of M cell formation and associated mononuclear cells during indomethacin-induced intestinal inflammation.

Lügering A, Floer M, Lügering N, Cichon C, Schmidt MA, Domschke W, Kucharzik T.

Clin Exp Immunol. 2004 May;136(2):232-8.

7.

Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway.

Gockel HR, Lügering A, Heidemann J, Schmidt M, Domschke W, Kucharzik T, Lügering N.

J Immunol. 2004 Apr 15;172(8):5103-9.

8.

Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin.

Maaser C, Heidemann J, von Eiff C, Lugering A, Spahn TW, Binion DG, Domschke W, Lugering N, Kucharzik T.

J Immunol. 2004 Apr 15;172(8):5056-62.

9.

Mucosal angiogenesis regulation by CXCR4 and its ligand CXCL12 expressed by human intestinal microvascular endothelial cells.

Heidemann J, Ogawa H, Rafiee P, Lügering N, Maaser C, Domschke W, Binion DG, Dwinell MB.

Am J Physiol Gastrointest Liver Physiol. 2004 Jun;286(6):G1059-68. Epub 2004 Feb 5.

10.

Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.

Heidemann J, Ogawa H, Dwinell MB, Rafiee P, Maaser C, Gockel HR, Otterson MF, Ota DM, Lugering N, Domschke W, Binion DG.

J Biol Chem. 2003 Mar 7;278(10):8508-15. Epub 2002 Dec 20.

11.

Induction of colitis in mice deficient of Peyer's patches and mesenteric lymph nodes is associated with increased disease severity and formation of colonic lymphoid patches.

Spahn TW, Herbst H, Rennert PD, Lügering N, Maaser C, Kraft M, Fontana A, Weiner HL, Domschke W, Kucharzik T.

Am J Pathol. 2002 Dec;161(6):2273-82.

12.

Mycobacterium avium subsp. paratuberculosis infection in a patient with HIV, Germany.

Richter E, Wessling J, Lügering N, Domschke W, Rüsch-Gerdes S.

Emerg Infect Dis. 2002 Jul;8(7):729-31.

13.

Compartment analysis of T cell receptor gamma--and immunoglobulin V(H) rearrangements by microdissection in patients with malt lymphoma and chronic gastritis with lymphatic hyperplasia.

Kraft M, Tiemann M, Riedel S, Gockel H, Kucharzik T, Parwaresch R, Domschike W, Lügering N.

Cell Mol Biol (Noisy-le-grand). 2002 May;48(3):253-63.

PMID:
12030429
14.

Interleukin 8 and Flt3 ligand as markers of advanced disease in primary gastrointestinal non-Hodgkin's lymphoma.

Retzlaff S, Padró T, Koch P, Oelmann E, Lügering N, Mesters RM, Berdel WE.

Oncol Rep. 2002 May-Jun;9(3):525-7.

PMID:
11956621
15.

Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches.

Spahn TW, Weiner HL, Rennert PD, Lügering N, Fontana A, Domschke W, Kucharzik T.

Eur J Immunol. 2002 Apr;32(4):1109-13.

16.

Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.

Heidemann J, Gockel HR, Winde G, Herbst H, Domschke W, Lügering N.

Z Gastroenterol. 2002 Jan;40(1):33-6.

PMID:
11803498
17.

Colorectal polyps: Detection with multi-slice CT colonography.

Wessling J, Fischbach R, Domagk D, Lügering N, Neumann E, Heindel W.

Rofo. 2001 Dec;173(12):1069-71.

PMID:
11740665
18.

CD4+ Th1-cells predominate in low-grade B-cell lymphoma of gastric mucosa-associated lymphoid tissue (MALT type).

Riedel S, Kraft M, Kucharzik T, Pauels HG, Tiemann M, Steinbüchel A, Domschke W, Lügering N.

Scand J Gastroenterol. 2001 Nov;36(11):1198-203.

PMID:
11686221
19.

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway.

Lügering A, Schmidt M, Lügering N, Pauels HG, Domschke W, Kucharzik T.

Gastroenterology. 2001 Nov;121(5):1145-57.

PMID:
11677207
20.

Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection.

Bantel H, Lügering A, Poremba C, Lügering N, Held J, Domschke W, Schulze-Osthoff K.

Hepatology. 2001 Oct;34(4 Pt 1):758-67.

PMID:
11584373
21.

Impact of miniprobes compared to conventional endosonography in the staging of low-grade gastric malt lymphoma.

Lügering N, Menzel J, Kucharzik T, Koch P, Herbst H, Tiemann M, Domschke W.

Endoscopy. 2001 Oct;33(10):832-7.

PMID:
11571677
22.

Aspirin effects on gastric epithelial cell proliferation and cytokine expression.

Pohle T, Becker JC, Markmann A, Lügering N, Pauels HG, Konturek JW, Domschke W.

Microsc Res Tech. 2001 Jun 1;53(5):354-9.

PMID:
11376496
23.

Role of M cells in intestinal barrier function.

Kucharzik T, Lügering N, Rautenberg K, Lügering A, Schmidt MA, Stoll R, Domschke W.

Ann N Y Acad Sci. 2000;915:171-83. Review.

PMID:
11193574
24.

Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells.

Dwinell MB, Lügering N, Eckmann L, Kagnoff MF.

Gastroenterology. 2001 Jan;120(1):49-59.

PMID:
11208713
25.
26.

Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis.

Schmidt M, Lügering N, Lügering A, Pauels HG, Schulze-Osthoff K, Domschke W, Kucharzik T.

J Immunol. 2001 Jan 15;166(2):1344-51.

27.

[Penetrating duodenal ulcer as the primary manifestation of intraductal papillary-mucinous pancreatic tumor].

Lügering A, Seidel M, Lügering N, Menzel J, Domschke W.

Z Gastroenterol. 2000 Nov;38(11):913-6. German.

PMID:
11132539
28.

[Classic case of benign recurrent intrahepatic cholestasis (Summerskill-Halshe-Tygstrup syndrome)].

Westermann G, Lügering N, August C, Rahn KH, Kisters K.

Med Klin (Munich). 2000 Jun 15;95(6):349-54. German.

PMID:
10935421
29.

IL-10 induces apoptosis in human monocytes involving the CD95 receptor/ligand pathway.

Schmidt M, Lügering N, Pauels HG, Schulze-Osthoff K, Domschke W, Kucharzik T.

Eur J Immunol. 2000 Jun;30(6):1769-77.

30.

[Signet ring cell carcinoma of the stomach--a case of diagnostic dilemma].

Lügering N, Menzel J, Westermann G, Domschke W.

Z Gastroenterol. 2000 Feb;38(2):177-80. German.

PMID:
10721175
31.

Characterization of M cell development during indomethacin-induced ileitis in rats.

Kucharzik T, Lügering A, Lügering N, Rautenberg K, Linnepe M, Cichon C, Reichelt R, Stoll R, Schmidt MA, Domschke W.

Aliment Pharmacol Ther. 2000 Feb;14(2):247-56.

32.
33.

Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta.

Schmidt M, Pauels HG, Lügering N, Lügering A, Domschke W, Kucharzik T.

J Immunol. 1999 Sep 15;163(6):3484-90.

34.

Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells.

Lügering N, Kucharzik T, Kraft M, Winde G, Sorg C, Stoll R, Domschke W.

Dig Dis Sci. 1999 Mar;44(3):649-55.

PMID:
10080164
35.

Decreased HER-2 tyrosine kinase expression in rectal mucosa of FAP patients following low-dose sulindac chemoprevention.

Winde G, Lügering N, Glodny B, Schmid KW, Müller O, Senninger N, Osswald H.

Cancer Lett. 1998 Dec 25;134(2):201-7.

PMID:
10025882
36.
37.

Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.

Lügering N, Kucharzik T, Stoll R, Domschke W.

Ital J Gastroenterol Hepatol. 1998 Jun;30(3):338-44. Review.

PMID:
9759608
38.

IL-10 synergizes with IL-4 and IL-13 in inhibiting lysosomal enzyme secretion by human monocytes and lamina propria mononuclear cells from patients with inflammatory bowel disease.

Lügering N, Kucharzik T, Stein H, Winde G, Lügering A, Hasilik A, Domschke W, Stoll R.

Dig Dis Sci. 1998 Apr;43(4):706-14.

PMID:
9558023
39.

[A system of nonspecific defense in chronic inflammatory bowel diseases--pathophysiologic and therapeutic aspects].

Lügering N, Kucharzik T, Stoll R, Domschke W.

Z Gastroenterol. 1998 Feb;36(2):173-87. Review. German.

PMID:
9544501
40.

Human intestinal M cells exhibit enterocyte-like intermediate filaments.

Kucharzik T, Lügering N, Schmid KW, Schmidt MA, Stoll R, Domschke W.

Gut. 1998 Jan;42(1):54-62.

41.

IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells.

Kucharzik T, Lügering N, Pauels HG, Domschke W, Stoll R.

Clin Exp Immunol. 1998 Jan;111(1):152-7.

42.

Colitis as the initial presentation of Wegener's granulomatosis.

Schneider A, Menzel J, Gaubitz M, Keller R, Lügering N, Domschke W.

J Intern Med. 1997 Dec;242(6):513-7.

43.

Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10.

Kucharzik T, Lügering N, Winde G, Domschke W, Stoll R.

Clin Exp Immunol. 1997 Nov;110(2):296-302.

44.

Differences in decorin and biglycan expression in patients with gastric ulcer healing.

Schönherr E, Lügering N, Stoll R, Domschke W, Kresse H.

Scand J Gastroenterol. 1997 Aug;32(8):785-90.

PMID:
9282970
45.

Cytomegalovirus encephalomyelomeningoradiculitis in acquired immunodeficiency syndrome (AIDS).

Lüttmann S, Husstedt IW, Lügering N, Heese C, Stoll R, Domschke W, Evers S, Kuchelmeister K, Gullotta F.

J Infect. 1997 Jul;35(1):78-81.

PMID:
9279730
46.

Importance of combined treatment with IL-10 and IL-4, but not IL-13, for inhibition of monocyte release of the Ca(2+)-binding protein MRP8/14.

Lügering N, Kucharzik T, Lügering A, Winde G, Sorg C, Domschke W, Stoll R.

Immunology. 1997 May;91(1):130-4.

47.

Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease.

Kucharzik T, Lügering N, Adolf M, Domschke W, Stoll R.

Dig Dis Sci. 1997 Apr;42(4):805-12.

PMID:
9125653
48.

Results and prognostic factors of splenectomy in idiopathic thrombocytopenic purpura.

Winde G, Schmid KW, Lügering N, Fischer R, Brandt B, Berns T, Bünte H.

J Am Coll Surg. 1996 Dec;183(6):565-74.

PMID:
8957458
50.

Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.

Kucharzik T, Lügering N, Weigelt H, Adolf M, Domschke W, Stoll R.

Clin Exp Immunol. 1996 Jun;104(3):483-90.

Supplemental Content

Loading ...
Support Center